If you’re nervous about having too much of the Magnificent Seven in your portfolio, consider the “Granolas.” That’s the acronym for 11 superstar European companies, including…
GSK (GSK), British pharmaceutical company with respiratory and HIV drugs. Recent share price: $42.42.
Roche Holding (RHHBY), Swiss biopharmaceutical firm with oncology therapies and in vitro testing. Recent share price: $31.95.
ASML Holding (ASML), Dutch semiconductor equipment maker. Recent share price: $992.95.
Nestlé (NSRGY), the world’s largest food and beverage manufacturer. Recent share price: $105.95.
Novartis (NVS), Swiss pharma firm treating heart disease and multiple sclerosis. Recent share price: $95.87.
Novo Nordisk (NVO), Danish maker of the obesity drug Ozempic. Recent share price: $127.55.
L’Oreal (LRLCY), French beauty products company. Recent share price: $94.25.
LVMH Moët Hennessy Louis Vuitton (LVMUY), French luxury-goods company. Recent share price: $179.96.
AstraZeneca (AZN), UK drugmaker with treatments for lung cancer and asthma. Recent share price: $67.25.
SAP (SAP), German software firm. Recent share price: $196.03.
Sanofi (SNY), French pharma company specializing in vaccines and heart disease. Recent share price: $48.29.
Most Granolas are still undervalued or fairly valued, although Morningstar rates ASML, Novo Nordisk and SAP as overvalued. These global leaders can grow earnings in tough environments and offer high profit margins, solid balance sheets and sustainable dividends.
Don’t want to invest in individual stocks? Gain exposure to the Granolas through the SPDR Euro Stoxx 50 ETF (FEZ).
